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Increased myeloperoxidase activity as an indicator of neutrophil-induced 
inflammation and sepsis in neonates 
 
INTRODUCTION 
Neutrophil plays a role as one of the frontline of 
body's defense against infection. These cells use 
bactericidal pathways that are oxygen dependent or 
independent as a weapon to eliminate infectious 
agents. Oxygen-dependent mechanism involves 
production of bactericidal reactive oxygen 
compounds. The mechanism oxygen-independent 
involves chemotaxis, phagocytosis, degranulation, 
and the release of lysis enzyme and bactericidal 
peptides1. 
MPO is an enzyme that contains heme secreted 
by phagocytic cells after the activation of the 
respiratory burst system. MPO is expressed mainly 
by neutrophils and monocytes in small quantities 
and it is very important to determine further process 
of hydrogen peroxide2. Most of the hydrogen 
peroxide produced by neutrophils will be consumed 
by the MPO. Hydrogen peroxide substrate is also 
derived from in vivo variety sources, including the 
leukocyte NADPH oxidase, xanthine oxidase, nitric 
oxide synthase (NOS) and various isoenzymes3.  
 
MPO has been implicated in promoting tissue 
damage in various inflammatory diseases, including 
acute respiratory distress syndrome, ischemia-
reperfusion injury, rheumatoid arthritis, bronchial 
asthma, and glomerulonephritis 4. 
The MPO level also increases in the lung during 
sepsis, which confirms the infiltration of lung 
parenchyma by neutrophils and reflects the severity 
of neutrophil-mediated organ damage5. MPO is 
usually used as a marker of neutrophil accumulation 
in tissues and a marker of neutrophil activity when 
it is measured in plasma6. 
The aim of our study is to evaluate neutrophil 
activation and the MPO enzyme activity in plasma 
as an indicator of sepsis as well as sepsis severity in 
neonates with sepsis with correlation to their 
clinical and laboratory findings. 
 
METHODS 
The current study was approved by the Ethical 
Committee of Pediatrics department, Ain Shams 
University. A written informed consent was taken 
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from parents before enrollment of neonates in the 
study. 
Myeloperoxidase enzyme activity was compared 
in 45 preterm and full term neonates to 30 healthy 
neonates with comparable gestation and birth 
weight. Out of 45 neonates with sepsis the severest 
15 were subjected to follow up sample to assess 
MPO serum level at 48-72 hours after the initial 
sample, to see if the marker has an early prognostic 
value (time when most neonates responding to 
antibiotics will show clinical and laboratory 
improvement).# All neonates with gestational age of 
e  28 weeks and up to 40 weeks admitted to NICU 
of  Maternity Hospital of Ain Shams University 
between January and December 2013 with proved 
sepsis (i.e. positive blood culture) or clinical sepsis 
(clinical signs of sepsis prompting five or more 
days of antibiotics, but the blood culture was 
negative) 7 were included. Neonates with Severe 
congenital anomalies, Chromosomal abnormalities 
and inborn errors of metabolism were excluded. 
All neonates were subjected to full history 
taking, thorough clinical examination, laboratory 
investigations which included complete blood count 
(CBC) using blood samples collected in EDTA 
tubes by Coulter counter T660 (USA) with 
differential leucocytic count using Leishman-
stained blood smear, C-reactive protein (CRP) 
estimated by latex agglutination assay (UK), and 
blood culture using a signal blood culture system 
(Oxoid, England). Myeloperoxidase enzyme 
activity was determined in the serum by Enzyme 
Linked Immunosorbent Assay (ELISA) (MPO 
Activity Assay Kit, BioVision Research Products, 
Mountain View, CA, USA). 
 
Statistical Methods 
Analysis of data was done by IBM computer using 
SPSS (Statistical Program for Social Sciences 
version 12). Quantitative variables were described 
as mean, SD, range, median and interquartile range. 
Qualitative variables were expressed as number and 
percentage. Chi-square test was used to compare 
qualitative variables between groups. Unpaired t-
test used to compare quantitative variables, in 
parametric data. Mann-Whitney test was used in 
non-parametric data. Spearman Correlation co-
efficient test used to correlate variables versus each 
other positively or inversely. ROC (receiver 
operator characteristic curve) was used to find out 
the best cut off to test the validity of certain 
variables (sensitivity, specificity, PPV and NPV). 




The present study included 45 newborns with 
sepsis; 24 males (53.3%) and 21 females (46.7%), 
and 30 healthy controls; 15 males (50%) and 15 
females (50%). Demographic characteristics of 
studied neonates are shown in table 1. 
Sixty percent of neonates in the sepsis group 
were delivered by CS as compared to 53.3% in the 
control group. Neonates in sepsis group had many 
risk factors for sepsis including PROM (33.3%), 
maternal UTI (44.4%), maternal fever (22.2%) and 
chorioamnionitis (15.5%). Fourteen neonates had 
septic shock (31.1%). Most of the neonates had late 
onset sepsis (73.3%) (sepsis starting in 2nd week of 
life). Most of our septic neonates were ventilated 
(68.9%), 15.6% needed CPAP and 11.1% needed 
oxygen by nasal cannula (one liter/minute or less) 
while 4.4% did not need any respiratory support.  
APGAR score at 1min and 5 min were significantly 
decreased in sepsis group compared to control 
group; p=0.00 and 0.02 respectively. 
The current study showed that there was 
significant decrease in segmented cell count and 
platelet count, while significant increase in I/T ratio 
and staff count, hematology and clinical septic 
score in sepsis compared to the control group. Also 
there was significant decrease in hemoglobin in 
sepsis group compared to control group; table 1. 
But we found no statistical difference in absolute 
neutrophil, lymphocyte count and serum creatinine 
between the two groups. 
There was significant higher in MPO level, CRP 
titre and direct billirubin, as well as significant 
increase in total billirubin levels, RBS and bleeding 
profile (PT, PTT and INR) in sepsis group 
compared to control group; table I. 
Forty two neonates (out of 45 neonates in sepsis 
group) had positive blood culture; gram positive 
cocci were detected in 17 patients, pseudomonas in 
5, coagulase negative staph. (CONS) in 2, 
klebsiella in 9 and E-coli in 9. Blood culture was 
negative in 3 patients in sepsis group. We found 
that there was significant positive correlation 
between the MPO levels and the APGAR score at 1 
minute, while there was no correlation with weight, 
G.A or APGAR score at 5 minute. Our study 
showed that there was highly significant positive 
correlation between the MPO level with WBCs; 
p=0.00, absolute and relative neutrophil count; 
p=0.00, and 0.00, staff count; p=0.00, segmented 
cell count; p=0.02, I/T ratio; p=0.00, Hematology 
septic score; p=0.01 and Clinical septic score; 0.00. 
But there was no correlation between the MPO 
level with lymphocytic cell count or platelet count 
or CRP titer in sepsis group.  
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As regard the follow up samples in 15 neonates 
with sepsis we found highly significant increase in 
HB, RBCs, abs. neutrophil count and WBCs in the 
follow up sample compared to the first sample. 
There was highly significant decrease in clinical 
septic score, staff count, I/T ratio and hematology 
sepsis score in follow up sample in comparison to 
first sample table 2. 
Table 2 showed also, the significant statistical 
difference between the first and follow up sample 
as there was significant decrease in lactate level, 
also significant increase in PH level and HCO3 level 
in follow up sample compared to first sample. 
There was no significant difference as regard PO2 
or PCO2 level in arterial blood gas. MPO levels 
decreased as the septic neonates improved in the 
follow up sample. Same finding were detected in 
CRP level. 
There was also a significant statistical difference 
as regard MPO level; P=0.02, as it was decreased in 
septic neonates with septic shock in comparison to 
septic neonates without septic shock median 67 vs 
149 mu/ml respectively.  
Of the 45 neonates in sepsis group 19 died, they 
had lower mean gestational age and lighter mean 
birth weight (31.1weeks and 1.6 kg respectively) 
compared to neonates who survived (36.1 weeks 
and 2.6 kg respectively) (p<0.05). Babies who died 
had lower mean total white blood cell count and 
lower mean serum MPO (p<0.05). Most of the 
neonates who died were suffering from severe 
shock or severe pneumonia.  The ROC Curve 
(figure 1) defined the best cutoff value for MPO in 
the diagnosis of sepsis was found to be > 54 mu/ml 
with a sensitivity of 100%, specificity of 62.2%, 
area under the curve of 77.7 and accuracy of 
81.11%. 
The ROC Curve of figure (2) showed that the 
best cut off point for MPO in prediction of 
mortality was found to be > 83 mu/ml with 
sensitivity of 53.33% and specificity of 88.46% 




Table 1. Comparison of laboratory parameters of the studied groups. 
 





Clinical septic score( Mean±SD) 6.5±2.5 1.4±0.8 7.20 0.00 
Hematology sepsis score (Mean±SD) 5.7±1.6 0.7±1.2 6.33 0.00 
HB(gm/dl) (Mean±SD) 13.2±2.8 14.5±1.3 2.23 0.02 
WBC(10³/mm) (Mean±SD) 11.5±6.5 10±2.5 -1.13 0.26 
Absolute nuetrophelic  count (10³/mm) (Mean±SD) 6.6±4.2 5.8±1.7 -1.07 0.28 
Segmented% (Mean±SD) 34.3±5.7 54±7.5 12.92 0.00 
staff %(median IQR) 20 (18 - 23) 2 (1 - 4) 7.31* 0.00 
I/T (median IQR) 0.35 (0.3 - 0.4) 0.04 (0.01 – 0.06) 7.30* 0.00 
Plt (10³/mm) (Mean ±SD) 114.7±83.9 234.1±59.9 6.71 0.00 
MPO (mU/ml) Median (IQR) 112 (75.7- 175.5) 29 (18  - 44) -5.94 0.00 
CRP (mg/L) Median (IQR) 96 (96 - 192) 0 (0  - 0) -7.93 0.00 
RBS (mg/dl) Median (IQR) 112 (78-214) 89 (79 - 105) -2.06 0.03 
Total bilirubin (mg/dl) Median (IQR) 10 (6.2 - 13.9) 6.65 (4.1- 10) -2.18 0.02 
Prothrombin time(sec.) PT Median (IQR) 20 (15 – 28.2) 14 (12 – 15) -4.52 0.00 
Partial thromboplastin time (sec.) PTT Median (IQR) 45 (35.5 – 55) 35 (32 – 39) -4.62 0.00 
INR          Median (IQR) 1.60 (1 – 2) 0.85 (0.6 – 1) -5.22 0.00 
Z*: Data are presented as median (IQR) and compared by Mann-Whitney test RBS = random blood sugar    WBCS = white blood 
cells     HB=hemoglobin    plt. = platelets count    CRP= C-reactive protein     I/T ratio = immature to total neutrophil count      
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n ( 15 ) 
Follow up sample 






Clinical septic score Mean+SD 7.8±1 6.2±2.1 2.35 0.00 
Hematology sepsis score Mean+SD 6.2±1.5 5.1±1.8 1.09 0.02 
HB(gm/dl) Mean+SD 10.5±2.4 15±1.7 8.50 0.00 
Staff % Median (IQR) 18 (15 – 22) 16 (3 – 19) 2.53* 0.02 
WBC(103/mm) Mean+SD 6.4±3.1 13.4±5.6 5.94 0.00 
abs.count(103/mm) Mean+SD 3.6±2.2 7.6±3.6 4.88 0.00 
I.T Median (IQR) 0.3 (0.3 - 0.4) 0.2 (0.2 - 0.3) 2.52* 0.02 
Plt(103/mm) Mean+SD 123±62 106.3±92.2 0.56 0.58 
PH Median (IQR) 7.2(7 - 7.4) 7.3 (7.2 - 7.3) 2.02* 0.04 
HCO3(mmol/l) Mean+SD 17.6±3.7 19.3±2 2.39 0.03 
Lactic (mmol/l)Median (IQR) 4.7 (1.3-5.8) 2.4 (1.3-3.8) 2.28* 0.02 
MPO (MU/ML) Median (IQR) 163 (108 – 213) 41 (31 - 49.5) 3.05* 0.00 
CRP (mg/dl) Median (IQR) 96 (96 – 192) 48 (0 – 48) 2.45* 0.01 
RBS (mg/dl) Median (IQR) 194(87.5-271.7) 76 (49 - 86.7) 2.10* 0.03 
WBCS = white blood cells   HB=hemoglobin    Abs.count = absolute neutrophil count     plt. = platelets count    
I/T ratio = immature to total neutrophil count   t: Data were presented as mean±SD and compared using 
paired t-test   Z*: Data are presented as median and IQR and compared using Wilcoxon rank test.  HCO3 = 
bicarb in blood     MPO = myeloperoxidase enzyme      CRP = C-reactive protein   RBS = random blood 




Figure 1. Receiver operating characteristic 
curve (ROC) for MPO in prediction of sepsis. 
Figure 2. Receiver operating characteristic curve 




Many studies have shown that in neonates signs of 
sepsis are nonspecific and are observed with other 
noninfectious conditions. Clinical criteria were 
unable to distinguish infected infants from 
uninfected infants7-9. 
According to Christensen10 leukocytosis and 
neutrophilia are unreliable indicators of neonatal 
sepsis. The reference range for these parameters 
changes daily, and may be influenced by many 
factor as gestational age, type of delivery and 
maternal hypertension. Neutropenia might even be 
better marker for sepsis11,12, if we can exclude other 
causes of neutropenia like preeclampsia, asphyxia 
and hemolytic disease of newborn. 
Serum C-reactive protein rises secondary to 
macrophage, T-cells or adipocyte production13. But 
not all neonates with systemic bacterial infections 
have elevated CRP with sensitivity anywhere 
between 50-90%14. Da Silva et al.15 showed in a 
comprehensive systematic review of the literature 
evaluating leukocyte ratios and CRP, a wide range 
of sensitivity (17% to 90%) and specificity (31% to 
100%) for leukocyte count and ratios. Similarly 
MPO in neonatal sepsis 
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CRP measurements showed variable accuracy, 
though better accuracy than the leukocyte 
parameters. Ng and Lam13 suggested that The CRP 
level is not recommended as a sole indicator of 
neonatal sepsis but may be used as part of a sepsis 
workup or as a serial study during infection to 
assess the response to antibiotics. 
According to Kothari et al.16, increased plasma 
MPO level is a marker of neutrophil proliferation 
and degranulation in humans as MPO constitutes 
5% of human PMN by weight and believed to 
represent a major pathway for oxygen dependent 
microbicidal activity. MPO catalyzes the formation 
of hypochlorous acid, a potent oxidant that has been 
implicated in killing bacteria17 and tissue 
destruction through induction of necrosis and 
apoptosis18. 
Our study shows high significance increase in 
MPO level in neonates with proven sepsis 
compared to healthy neonates, (p <0.01). This is in 
agreement with Nahm et al.19 and Basher et al.20 
who’s results of MPO studies in patients with sepsis 
and septic shock demonstrate that MPO blood level 
has a clear correlation with the severity of these 
pathological processes. This goes with Yunanto et 
al.21 study on neonates with early onset sepsis 
(EOS). They found significant increase in MPO 
blood level in septic neonates (623.52 ± 97.55 
ng/ml) compared with healthy control (360.95 ± 
142.72 ng/ml).  The Gustafsson et al.22 study on 
adult septic patient admitted to ICU revealed higher 
levels of  serum IL-6, IL-10, MPO and PCT in 
patients with severe sepsis compared to healthy 
controls (P = 0.001). 
In our study, there was significant correlation 
between MPO levels and previously described 
hematological marker of sepsis: total leukocytic 
count, absolute and relative neutrophil count, I/T 
ratio, staff count and with segmented cell (p= .022).  
This could be explained by Nicholls and Hazen3 
study which stated that MPO, through formation of 
secondary oxidants and nitration of protein tyrosine 
residues, could modulate intercellular signaling in 
the vasculature. Lau et al.23 found that MPO affect 
the activation state of neutrophils. Also, Yunanto et 
al.21 study showed significant positive correlation 
with neutrophil count in blood as well as saliva 
samples in neonates with EOS. 
Leviton et al.24 also stated that the 
concentrations of many inflammatory proteins 
including MPO: are higher in newborns exposed to 
inflammation with positive correlation to CRP. 
Similarly Kothari et al.16 study proved that MPO 
levels correlated linearly with sepsis severity except 
in advanced stages of septic shock. While Carr25 
stated that MPO is reduced in premature babies. 
Leviton et al.24 have found higher levels in 
premature babies which decrease as the baby 
matures. They explained that as in most previous 
studies of protein concentrations in preterm 
newborns, term newborns served as the comparison 
group. They, however, have evaluated protein 
concentrations within a narrow gestational age 
range, 23 to 27 6/7 weeks. They are reluctant to 
extrapolate the significance of their findings beyond 
this narrow range. 
In our study we found that patients with severe 
septic shock suffering from severe neutropenia 
usually have significant decrease in MPO (p <0.01) 
level up to being undetectable. Also MPO levels 
were positively correlated with neutrophil count. 
Both MPO and neutrophil count correlate inversely 
with septic shock severity as MPO plasma level is 
usually derived from neutrophils; its levels will 
decrease with the decrease of neutrophil count 
which goes with Kothari et al.16 study.  
Also we found marked decline in MPO level in 
follow up sample in comparison with first sample 
which could be explained by decrease in number of 
neutrophils with less degranulation and less MPO in 
serum which implicate that MPO has good 
prognostic value in sepsis in neonates. Kothari et 
al.16 study concluded that the plasma MPO 
concentration may be a marker of the neutrophil 
proliferation and severity of inflammation which is 
consisting enough with our results. In study by 
Vrba and Modriansky6 it was proved that MPO is 
usually used as a marker of accumulation of 
neutrophils in tissue and it is a marker of neutrophil 
activity measured in plasma which supports our 
study. 
In our study, the ROC curve and interactive dot 
diagram show that the best cut off point for MPO to 
prove sepsis in ill neonates was found to be >54 
mu/ml with a sensitivity of 100%, specificity, of 
62.2%, area under the curve of 77.7% and accuracy 
of 81.11%. Yunanto et al.21 have similar findings in 
saliva and blood sample of neonates with EOS. 
Also in our study, the ROC curve and interactive 
dot diagram showed that the best cut off point for 
MPO in prediction of mortality was found to be > 
83mu/ml with sensitivity of 53.33% and specificity 
of 88.46%. 
In conclusion we demonstrated that plasma 
MPO enzyme activity is a good biomarker of 
inflammatory response in neonates with sepsis 
regardless of weight or the gestational age, as well 
as sepsis severity, with cut off point for MPO >54 
mu/ml with a sensitivity of 100%, specificity of 
62.2% in prediction of septic patients. However 
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levels of MPO decrease in sepsis shock due to 
neutropenia associated with severe toxemia.  The 
best cut off point for MPO in prediction of 
mortality was found >83 mu/ml with sensitivity of 
53.33% and specificity of 88.46%. 
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